## MDB: MongoDB, Inc. - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_20 at 12.8% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($371.62)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. MongoDB Earnings: Accelerating Revenue Growth Drives Outsize Operating Leverage**
- Source: Morningstar | 20251203T090940 | Neutral | Relevance: 100%
- MongoDB reported strong earnings with a 19% increase in total revenue and 30% growth in Atlas revenue year-over-year. The company demonstrated significant operating leverage, with non-GAAP operating margin projected to improve by nearly 300 basis points for fiscal 2026. However, despite a raised fair value estimate to $303 per share, the stock remains overvalued due to strong market enthusiasm.

**2. MongoDB Q3 2025 Earnings: Revenue Jumps 18.7%, Beats Expectations | NASDAQ:MDB - News and Statistics**
- Source: IndexBox | 20251203T041037 | Bullish | Relevance: 100%
- MongoDB reported strong third-quarter 2025 results, with revenue of $628.3 million, an 18.7% increase year-over-year, and non-GAAP profit of $1.32 per share, both beating analyst expectations. The company also raised its full-year Adjusted EPS guidance and saw significant growth in its customer base and Atlas cloud database platform. Management expressed confidence in its position for the AI era and expects continued expansion.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 27, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Argus Research | $488 | $340 | +44% |
| 2025-12-03 | Citigroup | $525 | $440 | +19% |
| 2025-12-03 | Goldman Sachs | $475 | $405 | +17% |
| 2025-12-02 | Baird | $500 | $335 | +49% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Argus Research | main | Buy |
| 2025-12-03 | Citigroup | main | Buy |
| 2025-12-03 | Goldman Sachs | main | Buy |
| 2025-12-02 | Baird | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 17 ($14.36M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 11.0% (+5.0%)
- Blackrock Inc.: 6.1% (+3.6%)
- Morgan Stanley: 3.3% (+52.2%)
- JPMORGAN CHASE & CO: 2.8% (+34.0%)
- ValueAct Holdings, L: 2.6% (+206.8%)

### Key Risks

1. Heavy insider selling: $14M sold (17 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 27 raises (avg +19%) could attract flows.
- Momentum building: MRS_20 improving +18.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.67 elevated, pricing in significant growth expectations. Forward P/E 73.8x stretched relative to 15% growth. Balance sheet: strong liquidity (5.2x), low leverage (D/E 0.23). Analyst sentiment positive (27 raises, avg +19%). Insider selling cluster ($14.4M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.5B |
| Beta | 1.45 |
| 52W Range | $140.78 - $440.67 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.67 |
| Forward P/E | 73.8 |
| Current P/E | 85.1 |
| YoY Growth | 15.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -5.9% to 12.8% (+18.7% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (12.8% > 10.0%), caution on chasing. MRS_5 at 4.8% confirms short-term momentum alignment. AM_20 at 15.3% shows strong absolute momentum above own 20MA. Outperforming sector by 12.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (7.45), confirming momentum. RSI overbought at 70, risk of mean reversion. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 12.79% (CS: 98) | Strong |
| RSI_14 | 70.4 | Overbought |
| MACD Histogram | 7.45 | Bullish |
| vs SMA20 | 1.153x | Above |
| vs SMA50 | 1.204x | Above |
| vs SMA200 | 1.646x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $409.62
- **Stop Loss:** $371.62 (9.3% risk)
- **Target:** $447.62 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 26
- **Position Value:** $10,650.12
- **Portfolio %:** 10.65%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-03-05 (Est: $1.48)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.79 | $1.32 | +66.9% |
| 2025Q3 | $0.66 | $1.00 | +52.4% |
| 2025Q2 | $0.66 | $1.00 | +52.0% |
| 2025Q1 | $0.67 | $1.28 | +91.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*